These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
119 related items for PubMed ID: 22783583
21. [Personal experience with determination of NT-proBNP in clinical practice]. Stejskal D, Oral I, Lacnák B, Juráková R, Horalík D, Adamovská S, Prosková J, Hrabovská I, Ozanová G. Vnitr Lek; 2003 Feb; 49(2):121-6. PubMed ID: 12728579 [Abstract] [Full Text] [Related]
22. N-terminal pro-B-type natriuretic peptide testing improves the management of patients with suspected acute heart failure: primary results of the Canadian prospective randomized multicenter IMPROVE-CHF study. Moe GW, Howlett J, Januzzi JL, Zowall H, Canadian Multicenter Improved Management of Patients With Congestive Heart Failure (IMPROVE-CHF) Study Investigators. Circulation; 2007 Jun 19; 115(24):3103-10. PubMed ID: 17548729 [Abstract] [Full Text] [Related]
23. Evaluation of N-terminal pro-B type natriuretic peptide analysis on the Elecsys 1010 and 2010 analysers. Barnes SC, Collinson PO, Galasko G, Lahiri A, Senior R. Ann Clin Biochem; 2004 Nov 19; 41(Pt 6):459-63. PubMed ID: 15588434 [Abstract] [Full Text] [Related]
24. Differentiation of Cardiac from Noncardiac Pleural Effusions in Cats using Second-Generation Quantitative and Point-of-Care NT-proBNP Measurements. Hezzell MJ, Rush JE, Humm K, Rozanski EA, Sargent J, Connolly DJ, Boswood A, Oyama MA. J Vet Intern Med; 2016 Nov 19; 30(2):536-42. PubMed ID: 26813037 [Abstract] [Full Text] [Related]
25. Analytical evaluation of the Dade Behring Dimension RxL automated N-Terminal proBNP (NT-proBNP) method and comparison with the Roche Elecsys 2010. Di Serio F, Ruggieri V, Varraso L, De Sario R, Mastrorilli A, Pansini N. Clin Chem Lab Med; 2005 Nov 19; 43(11):1263-73. PubMed ID: 16232094 [Abstract] [Full Text] [Related]
26. Midregional pro-atrial natriuretic peptide is a useful indicator for the detection of impaired left ventricular function in patients with coronary artery disease. Elmas E, Brueckmann M, Lang S, Kälsch T, Haghi D, Sueselbeck T, Dempfle CE, Borggrefe M. Int J Cardiol; 2008 Aug 18; 128(2):244-9. PubMed ID: 17673312 [Abstract] [Full Text] [Related]
27. Clinical utility of serum N-terminal pro-B-type natriuretic peptide concentration for identifying cardiac disease in dogs and assessing disease severity. Oyama MA, Fox PR, Rush JE, Rozanski EA, Lesser M. J Am Vet Med Assoc; 2008 May 15; 232(10):1496-503. PubMed ID: 18479239 [Abstract] [Full Text] [Related]
31. Two-year stability of NT-proBNP in frozen samples using the Roche Elecsys system. Cauliez B, Guignery J, Marinier S, Mariau I, Lavoinne A. Ann Clin Biochem; 2008 May 13; 45(Pt 3):318-9. PubMed ID: 18482923 [Abstract] [Full Text] [Related]
32. The diagnostic accuracy of different natriuretic peptides in the investigation of canine cardiac disease. Boswood A, Dukes-McEwan J, Loureiro J, James RA, Martin M, Stafford-Johnson M, Smith P, Little C, Attree S. J Small Anim Pract; 2008 Jan 13; 49(1):26-32. PubMed ID: 18005104 [Abstract] [Full Text] [Related]